Aliter-backed Halcyon completes investment in FingerPrint Global

Aliter Capital LLP (Aliter), a specialist investor focused on small to mid-sized UK Support Services businesses, has announced the completion of an investment in FingerPrint Global Ltd (FingerPrint). Aliter is currently investing from its recently announced £134m second fund, Aliter Capital II.

This represents Aliter’s second investment within its ‘Halcyon’ platform which aims to create a market leading, UK-based healthcare-focused software and data analytics group.

FingerPrint is a provider of specialist audit and lifecycle tracking ‘Track & Trace’ solutions related to the sterilisation and decontamination of surgical instruments within clinical environments. The business has an extensive library of procedures, supporting data streams and a proven ability to capture market share through product innovation and longstanding customer relationships.

FingerPrint becomes part of Aliter’s Halcyon platform, joining existing portfolio company Net Solving, a digital health data analytics platform providing web-based data collection systems for clinical audits, disease and patient registries and quality improvement programmes.

PMSI provided the CDD for the deal, including an in-depth assessment of the ‘Track and Trace’ solutions market and FingerPrint’s competitive positioning, as well as a full customer referencing process.

“We chose to work with PMSI given their strong experience in the healthtech space. Gareth and the PMSI team delivered – with clear commercial insights and deep sector knowledge that really informed our investment decision-making.” Gordon Cooper, Group CEO of Halcyon Healthcare

Aliter-backed Halcyon completes investment in FingerPrint (